Which are the causes of Lennox-Gastaut syndrome?

Lennox-Gastaut syndrome is a severe form of childhood-onset epilepsy that does not have a single, universal cause; rather, it is a clinical manifestation resulting from various underlying brain insults or genetic anomalies. In approximately 70% to 80% of patients, a specific predisposing factor can be identified, while in the remaining cases, the exact etiology remains unknown or "cryptogenic."

What are the underlying causes of Lennox-Gastaut syndrome?

Lennox-Gastaut syndrome is considered a "syndrome of convergence," meaning different types of brain injuries or genetic disruptions can lead to the same clinical picture of frequent, treatment-resistant seizures and specific EEG patterns. The brain acts like a complex electrical circuit; when structural or chemical damage occurs during early development, the network can become prone to the widespread, disorganized electrical activity that characterizes Lennox-Gastaut syndrome. Common underlying causes include brain malformations, perinatal hypoxia (lack of oxygen during birth), and severe head trauma.

Is there a genetic component to Lennox-Gastaut syndrome?

While Lennox-Gastaut syndrome is typically not inherited from parents in a straightforward way, genetic factors play a significant role. Emerging research shows that many cases are linked to de novo mutations—new genetic changes that occur in the child but are not present in either parent. Several genes associated with neuronal development and ion channel function have been implicated. For example, mutations in genes such as GABRB3, CDKL5, and SCN1A have been identified in a subset of patients. Genetic counseling is vital for families, as these findings can help distinguish between sporadic genetic events and rare hereditary conditions.

What are the known risk factors and triggers?

Distinguishing between a direct cause and a risk factor is essential for clinical management. A cause is the primary insult (like a stroke or genetic mutation), whereas a risk factor may increase susceptibility to the syndrome's progression. Documented clinical factors associated with the development of Lennox-Gastaut syndrome include:

• Structural brain abnormalities: Cortical dysplasia or tuberous sclerosis complex.


• Infectious history: Severe cases of meningitis or encephalitis in early childhood.


• Metabolic disorders: Certain rare metabolic conditions that affect how brain cells produce or use energy.


• Perinatal complications: Intrauterine growth restriction or hypoxic-ischemic encephalopathy.

Is the etiology of Lennox-Gastaut syndrome fully understood?

Despite significant advancements in genomic sequencing, the etiology of Lennox-Gastaut syndrome remains an active area of research. Currently, about 20% to 30% of cases are classified as idiopathic or cryptogenic, meaning we cannot yet pinpoint the precise biological trigger. Scientists are currently using "multi-omics" approaches—combining genetic, proteomic, and clinical data—to better understand why these diverse insults converge into the specific, devastating seizure patterns seen in Lennox-Gastaut syndrome. This ongoing research is critical for developing precision medicine therapies that target the root cause rather than just managing symptoms.

How does the DiseaseMaps community support this research?

At DiseaseMaps.org, we have 105 people with Lennox-Gastaut syndrome who have joined our community. By sharing their lived experiences and clinical histories, these families provide invaluable observational data that help researchers identify patterns, potential triggers, and the long-term impact of various treatment pathways for those living with Lennox-Gastaut syndrome.

Next steps

• Consult with a pediatric neurologist or epileptologist to discuss comprehensive genetic testing, such as whole-exome sequencing.


• Maintain a detailed seizure diary to help your medical team identify potential external triggers.


• Connect with the DiseaseMaps community to share experiences and learn from others navigating a diagnosis of Lennox-Gastaut syndrome.


• Stay informed about clinical trials investigating novel anti-seizure medications and gene therapies through the NIH ClinicalTrials.gov portal.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Lennox-Gastaut Syndrome Overview.


• Orphanet: Rare Disease Database (ORPHA: 2313).


• Online Mendelian Inheritance in Man (OMIM): Entry #605963 (Lennox-Gastaut Syndrome).


• LGS Foundation: Clinical resources and patient support information.